FRLN - Freeline Therapeutics to be acquired by Syncona for $28.3M in cash
2023-11-22 07:51:12 ET
More on Freeline Therapeutics
- Freeline gains on non-binding buyout offer from Syncona
- Freeline posts early data for gene therapy in Gaucher disease
- Seeking Alpha’s Quant Rating on Freeline Therapeutics
- Historical earnings data for Freeline Therapeutics
- Financial information for Freeline Therapeutics
For further details see:
Freeline Therapeutics to be acquired by Syncona for $28.3M in cash